Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
299.70
-13.05 (-4.17%)
Jan 27, 2026, 4:00 PM EST - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $8.11 billion as of January 28, 2026. Its market cap has decreased by -15.92% in one year.
Market Cap
8.11B
Enterprise Value
8.08B
1-Year Change
-15.92%
Ranking
Category
Stock Price
$299.70
Market Cap Chart
Since January 28, 2021, Bio-Rad Laboratories's market cap has decreased from $16.89B to $8.11B, a decrease of -52.01%. That is a compound annual growth rate of -13.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 8.06B | -1.22% |
| Dec 31, 2025 | 8.16B | -11.31% |
| Dec 31, 2024 | 9.20B | -1.07% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 33.88% |
| Jan 28, 2021 | 16.89B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zimmer Biomet Holdings | 17.16B |
| Smith & Nephew | 14.14B |
| Penumbra | 14.07B |
| Globus Medical | 12.38B |
| Bio-Rad Laboratories | 8.00B |
| Bruker | 7.65B |
| Masimo | 7.60B |
| Glaukos | 6.89B |